Schrödinger, Inc. (NASDAQ:SDGR) Shares Bought by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its stake in Schrödinger, Inc. (NASDAQ:SDGR) by 4.1% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 498,513 shares of the company’s stock after acquiring an additional 19,436 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Schrödinger were worth $9,247,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of SDGR. Nisa Investment Advisors LLC raised its holdings in Schrödinger by 145.3% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock worth $27,000 after buying an additional 837 shares during the period. KBC Group NV increased its position in shares of Schrödinger by 45.4% in the third quarter. KBC Group NV now owns 2,508 shares of the company’s stock worth $47,000 after acquiring an additional 783 shares in the last quarter. nVerses Capital LLC acquired a new stake in shares of Schrödinger during the second quarter valued at approximately $66,000. Quest Partners LLC boosted its stake in Schrödinger by 1,005.6% in the 2nd quarter. Quest Partners LLC now owns 4,555 shares of the company’s stock worth $88,000 after purchasing an additional 4,143 shares during the period. Finally, Private Advisor Group LLC grew its position in Schrödinger by 20.5% during the 3rd quarter. Private Advisor Group LLC now owns 12,150 shares of the company’s stock worth $225,000 after purchasing an additional 2,065 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently issued reports on SDGR shares. BMO Capital Markets increased their target price on Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Morgan Stanley decreased their price objective on Schrödinger from $43.00 to $30.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 21st. Three equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Schrödinger currently has an average rating of “Moderate Buy” and a consensus target price of $32.90.

Schrödinger Price Performance

Shares of NASDAQ:SDGR opened at $21.67 on Tuesday. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of -9.26 and a beta of 1.56. The business’s fifty day moving average price is $19.20 and its two-hundred day moving average price is $20.11. Schrödinger, Inc. has a fifty-two week low of $16.67 and a fifty-two week high of $38.00.

Schrödinger (NASDAQ:SDGR) last announced its earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.12). The business had revenue of $35.30 million during the quarter, compared to analyst estimates of $41.25 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The business’s quarterly revenue was down 17.1% compared to the same quarter last year. During the same quarter last year, the business posted ($0.86) earnings per share. Research analysts expect that Schrödinger, Inc. will post -2.29 EPS for the current fiscal year.

Insider Buying and Selling

In other Schrödinger news, insider Margaret Dugan sold 1,531 shares of Schrödinger stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total transaction of $27,221.18. Following the completion of the sale, the insider now owns 13,469 shares of the company’s stock, valued at approximately $239,478.82. The trade was a 10.21 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 8.60% of the company’s stock.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.